What is Ortin Global Ltd (ORTINGLOBE) share price return in the past 10 years?

Ortin Global Ltd share price has appreciated 0.6% annually (CAGR) over the past ten years.

What is the share price of Ortin Global Ltd (ORTINGLOBE)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ortin Global Ltd (ORTINGLOBE) on 04-Jun-2026 16:59:59 at 16:59 is 15.90.

What is the P/E ratio of Ortin Global?

The latest standalone P/E ratio of Ortin Global as of 04-Jun-2026 is 0.00.

What is the P/B ratio of Ortin Global Ltd (ORTINGLOBE)?

The latest standalone P/B ratio of Ortin Global Ltd (ORTINGLOBE) as of 04-Jun-2026 is 10.42.

What is the 52-week high and low of Ortin Global Ltd (ORTINGLOBE)?

The 52-week high of Ortin Global Ltd (ORTINGLOBE) is Rs. 19.15 and the 52-week low is Rs. 10.56.

Ortin Global Ltd (ORTINGLOBE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Ortin Global Ltd (ORTINGLOBE)
Brand: Ortin Global

Key Metrics

Valuation Multiples

Market Cap

₹13 Cr.

Current Price

₹15.9

52-Week Low / High

₹11 / 19

TTM EPS

₹-0.9

TTM Sales

₹0.1 Cr.

Book Value per Share

₹1.5

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

10.42

Higher than its 5-year historical median

Price to Sales (P/S)

128.01

Higher than its 5-year historical median

EV/EBITDA

-18.49

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-35.26%

Underperforms industry median

Return on Capital Employed (ROCE)

-24.36%

Underperforms industry median

Return on Assets (ROA)

-14.82%

Operating Profit Margin

-258.2%

Net Profit Margin

-247.34%

Gross Profit Margin

-246.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-83.89%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

1.23%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-7 Cr.

Equity

₹8.1 Cr.

Face Value

₹10

All Time Low / High

₹6.60 / 52.25

Ortin Global stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Ortin Global Ltd a good quality company?

Ortin Global Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Ortin Global Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Ortin Global Ltd vs industry peers?

Ortin Global Ltd revenue CAGR is -72.00%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Ortin Global Ltd?

Promoters hold 1.23% of the Ortin Global Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Ortin Global Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -1.8% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	11%	9.6%	10.1%	11.8%	8.9%	3.3%	1.6%	1.7%	-60.1%	-24.4%	-
Value Creation Index ⓘ	-0.2	-0.3	-0.3	-0.2	-0.4	-0.8	-0.9	-0.9	-5.3	-2.7	-
Growth Parameters ⓘ
Sales ⓘ	62.9	66.8	79.7	168	197	8.2	8.2	6	2.1	0.3	0
Sales YoY Gr.	-	6.1%	19.4%	110.5%	17.7%	-95.9%	0.7%	-26.9%	-65%	-83.9%	-
Adj EPS ⓘ	0.5	0.2	0.3	0.8	-0.3	1.2	-0.5	-0.1	-8	-1.1	-0.9
YoY Gr.	-	-50%	37.5%	127.3%	-142.7%	NA	-142.2%	NA	NA	NA	-
BVPS (₹) ⓘ	13.7	13.8	14.2	14.8	14.1	14	13.5	13.4	3.5	2.4	1.5
Adj Net Profit ⓘ	0.8	0.4	0.6	1.3	-0.6	1	-0.4	-0.1	-6.5	-0.9	-1
Cash Flow from Ops. ⓘ	0.5	1.9	1.6	6.5	3.3	18	2.2	-0.3	-4.8	-0.4	-
Debt/CF from Ops. ⓘ	40.4	8.9	11.1	3	5.9	0.4	2.9	-25.5	-0.4	-0.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-44%	-72%	-65.4%	-83.9%
Adj EPS ⓘ	-209.2%	NA	NA	NA
BVPSⓘ	-17.5%	-29.6%	-43.5%	-30%
Share Price	0.6%	-10.6%	-6.4%	36.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.5	1.8	2.4	5.2	-2.2	5.4	-3.6	-0.7	-95.5	-35.8	-46
Op. Profit Mgn % ⓘ	9.4	8	6.9	3.7	2.9	15.3	4.6	8.7	-207.8	-258.2	-630.8
Net Profit Mgn % ⓘ	1.3	0.6	0.7	0.8	-0.3	11.6	-4.8	-1.4	-309.5	-251.3	-739.8
Debt to Equity ⓘ	0.9	0.7	0.7	0.8	0.8	0.6	0.6	0.6	0.6	0.1	0.8
Working Cap Days ⓘ	235	223	205	144	159	2,175	261	364	1,029	4,636	7,893
Cash Conv. Cycle ⓘ	117	127	118	61	51	263	182	256	601	1,073	3,737

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	62.94	66.75	79.71	167.76	197.39	8.17	8.23	6.02	2.11	0.34
Operating Expenses ⓘ +	57.05	61.40	74.31	161.52	191.71	6.92	7.86	5.50	8.65	1.23
Manufacturing Costs	10.23	9.44	9.54	18.21	26.57	0.51	0.52	0.39	0.59	0.09
Material Costs	41.33	45.59	57.59	134.82	154.62	3.95	4.65	3.39	3.72	0.21
Employee Cost	2.13	2.59	2.78	3.68	4.72	0.85	0.74	0.68	0.49	0.09
Other Costs ⓘ	3.37	3.78	4.39	4.82	5.80	1.61	1.95	1.04	3.86	0.84
Operating Profit ⓘ	5.89	5.35	5.40	6.24	5.68	1.25	0.38	0.52	-6.54	-0.88
Operating Profit Margin (%)	9.4%	8.0%	6.8%	3.7%	2.9%	15.2%	4.6%	8.6%	-309.0%	-258.0%
Other Income ⓘ +	0.57	0.42	0.45	0.57	0.20	0.05	0.19	0.04	0.17	0.04
Exceptional Items ⓘ	0	0	0	0	0	0	0	-0.03	-0	0.02
Interest ⓘ	3.42	2.94	3.49	3.22	3.21	0.87	0.81	0.40	0.48	0
Depreciation ⓘ	1.65	1.70	1.69	1.75	1.96	0.29	0.29	0.25	0.23	0.01
Profit Before Tax ⓘ	1.40	1.13	0.68	1.84	0.72	0.14	-0.53	-0.11	-7.08	-0.84
Tax ⓘ	0.56	0.63	0	0.56	1.28	-0.81	-0.13	-0.02	0.97	0.01
Profit After Tax	0.83	0.50	0.68	1.28	-0.56	0.95	-0.40	-0.09	-8.04	-0.85
PAT Margin (%)	1.3%	0.8%	0.9%	0.8%	-0.3%	11.6%	-4.8%	-1.6%	-380.0%	-247.0%
Adjusted EPS (₹)	0.5	0.3	0.4	0.8	-0.3	1.2	-0.5	-0.1	-9.9	-1.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Ortin Global - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	23.27	23.40	24.08	25.09	23.82	11.36	10.96	10.86	2.82	1.98
Share Capital ⓘ	16.94	16.94	16.94	16.94	16.94	8.13	8.13	8.13	8.13	8.13
Reserves ⓘ	6.33	6.46	7.14	8.15	6.88	3.22	2.83	2.73	-5.31	-6.15
Debt +	20.02	16.54	16.14	19.47	19.57	6.94	6.14	6.45	1.80	0.25
Long Term Debt	4.80	1.42	1.48	4.74	4.90	1.44	1.73	2.96	1.80	0.25
Short Term Debt	15.22	15.12	14.66	14.74	14.67	5.50	4.42	3.48	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	2.81	7.05	16.58	47.60	60	1.34	0.79	1.55	0.08	0.04
Others Liabilities ⓘ	19.71	14.54	16.86	12.92	13.13	1.63	2.82	2.34	3	1.45
Total Liabilities ⓘ	65.82	61.53	73.66	105.09	116.52	21.27	20.70	21.20	7.71	3.72
Fixed Assets
Net Fixed Assets ⓘ +	21.63	20.69	20.03	21.29	22.45	14.38	14.21	13.96	0.01	0
Gross Block	32.93	22.35	23.31	26.32	29.44	18.91	19.04	18.78	0.21	0.21
Accumulated Depreciation	11.30	1.67	3.28	5.03	6.99	4.54	4.83	4.82	0.20	0.21
CWIP ⓘ	0	0.35	0.40	0.53	0.43	0.43	0.43	0.43	0	0
Investments ⓘ	0.03	0.07	0.08	0.08	0.07	0	0	0	0	0
Inventories	16.84	17.65	24.02	36.96	49.90	1.83	1.74	2.60	0.05	0.02
Trade Receivables	9.13	15.24	21.85	37.83	37.15	3.91	3.24	3.42	1.77	0.26
Cash Equivalents	1.66	1.43	1.69	2.14	2.50	0.18	0.60	0.26	2.34	0.37
Others Assets ⓘ	16.53	6.10	5.59	6.25	4.02	0.54	0.49	0.54	3.54	3.06
Total Assets ⓘ	65.82	61.53	73.66	105.09	116.52	21.27	20.70	21.20	7.71	3.72

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.52	1.94	1.56	6.52	3.30	18.03	2.15	-0.25	-4.79	-0.41
PBT ⓘ	1.40	1.13	0.68	1.84	0.72	0.14	-0.53	-0.11	-7.08	-0.84
Adjustment ⓘ	4.49	1.69	1.39	5.21	5.41	1.16	1.10	0.64	2.86	0.01
Changes in Working Capital ⓘ	-1.46	-0.26	0.06	-0.1	-1.99	16.74	1.58	-0.78	0.72	0.41
Tax Paid ⓘ	-0.50	-0.62	-0.58	-0.42	-0.83	0	0	0	-1.29	0
Cash Flow From Investing Activity ⓘ +	-0.86	-1.26	-0.90	-3.27	-3.09	0.07	-0.13	0.01	12	-0
Capex	-1.44	-0.76	-0.74	-3.01	-3.12	0	-0.13	0.01	12	-0
Net Investments	0	-0.01	-0.01	-0.01	-0.08	0.07	0	0	0	0
Others ⓘ	0.57	-0.49	-0.15	-0.25	0.10	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.27	-0.82	0.07	-2.89	-1.33	-9.86	-0.47	0.90	-3.49	0.33
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.27	-0.82	0.07	0.33	3.09	-3.46	0	0	-1.16	-1.55
Interest Paid ⓘ	0	0	0	-3.22	-3.21	-0.87	-0.81	-0.40	-0.48	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	-1.21	-5.52	0.34	1.30	-1.85	1.88
Net Cash Flow ⓘ	-0.07	-0.14	0.73	0.37	-1.12	8.25	1.55	0.66	3.72	-0.09

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3.65	2.16	2.86	5.21	-2.31	5.38	-3.57	-0.86	-117.48	-35.26
ROCE (%)	11.01	9.58	10.14	11.76	8.93	3.27	1.56	1.66	-60.11	-24.36
Asset Turnover Ratio	1.01	1.05	1.19	1.88	1.78	0.12	0.39	0.29	0.15	0.06
PAT to CFO Conversion(x)	0.63	3.88	2.29	5.09	N/A	18.98	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	71.30	66.60	84	64.90	69.30	917.70	158.60	201.70	448.10	1,081.40
Inventory Days	105.40	94.30	94.30	66.30	80.30	1,156	79.20	131.50	228.90	37.30
Payable Days	86.80	39.50	74.90	86.90	127	2,833.90	83.40	125.70	79.80	102.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ortin Global Ltd FAQs

The current trading price of Ortin Global on 04-Jun-2026 16:59 is ₹15.90.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Ortin Global stood at ₹12.93 Cr

The latest P/E ratio of Ortin Global as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Ortin Global as of 03-Jun-2026 is 10.42.

The 52-week high of Ortin Global is ₹19.15 and the 52-week low is ₹10.56.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ortin Global is ₹0.10 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ortin Global Ltd is a below average quality company.

The key valuation ratios of Ortin Global Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ortin Global Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Ortin Global Ltd

Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Quality is the hallmark of Ortin. At every stage of production from raw material to finished products, highest standard of quality is ensured with the help of most modern equipment and experienced personnel.This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade.

Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the ministry of health regularly inspect the company's plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.

Ortin is contemplating an entry into the OTC segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind them is only the Reliance which they carry for their Quality from the people all over the country. Their motto, right from their inception has been towards Quality and they still maintain them and continue to do so in future.

Products manufactured by the company include:

Capsules
Syrups / Dry syrups
Powders
Second Division Products
Generic Products

Achievements/ recognition :

Ortin has been certified as an ISO 9001: 2000 company by the internationally recognized Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc.

Ortin Global Ltd (ORTINGLOBE)

Ortin Global Ltd (ORTINGLOBE)

Ortin Global stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ortin Global - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ortin Global Ltd FAQs

About Ortin Global Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ortin Global Ltd (ORTINGLOBE)

Ortin Global Ltd (ORTINGLOBE)

Ortin Global stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ortin Global - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ortin Global Ltd FAQs

What is the share price of Ortin Global?

What is the market cap of Ortin Global?

What is the P/E ratio of Ortin Global?

What is the P/B ratio of Ortin Global?

What is the 52-week high and low of Ortin Global?

What is the TTM revenue of Ortin Global?

Is Ortin Global Ltd a good quality company?

Is Ortin Global Ltd undervalued or overvalued?

Is Ortin Global Ltd a good buy now?

About Ortin Global Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.